Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500) and the Nasdaq (COMP:IND) ending the week in the ...

Cramer Loves These Dividend Stocks

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...
Hosted on MSN

CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound

A class action lawsuit has been filed against CVS Caremark (NYSE:CVS), the pharmacy benefit manager for health insurer Aetna, after it dropped Eli Lilly's (NYSE:LLY) weight loss med Zepbound ...
NBC Los Angeles

Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Despite last ...
NBC Los Angeles

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Stream Los Angeles News for ...

Eli Lilly to spend $6B on AL plant for next-gen drugs. What to know

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...

Pharmaceutical giant Eli Lilly announces plans for $6B manufacturing plant in Huntsville

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...
NBC 10 Philadelphia

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Starting July 1, Caremark ...